Background: The objective of this study is to determine the efficacy of Vitamin E in the treatment of primary dysmenorrhoea compared to the placebo.Methods: Sixty women, aged 17-25 years old who suffered from primary dysmenorrhoea, among 1000 Women attending the gynec OPD in Kilpauk Medical College. 30 women were given 200 units of vitamin E (each tablet twice daily) and 30 were given a placebo tablets (each tablet twice daily). The treatment began two days before the beginning of menstruation and continued through the first three days of bleeding. The severity of pain and duration of pain before and after the treatment was studied. Treatment in both groups was carried out in three consecutive menstrual periods.Results: As to the findings, the mean age of the participants was 22.6 years. There was a significant difference between the pre- and post-treatment periods in terms of pain severity (P=0.72 and P=0.002, respectively) and pain duration (P=0.514 and P=0.027, respectively) in Vitamin E group. There was a significant difference observed between the Vitamin E group and placebo group regarding the mean of pain severity and duration (P=0.002 and p=0.027 respectively).Conclusions: Vitamin E helps to relieve pain in primary dysmenorrhoea. As this is a relatively easier method for control of pain with lesser amount of side effects and as it is cost effective, it can be considered as a universal drug in the treatment of primary dysmenorrhoea.
Background: Hypothyroidism is associated with maternal and fetal complications. This study aims to evaluate the prevalence, maternal and fetal outcome in hypothyroidism. Objective of this study was to determine whether thyroid function test can be recommended as a universal or selective screening in pregnancy.Methods: An analytical cross-sectional study with internal comparison carried out at Govt. Kilpauk Medical College & Hospital from September 2017 to July 2018 for antenatal mothers in third trimester. Serum TSH and freeT3, T4 in case of abnormal TSH were measured, grouped into subclinical and overt hypothyroidism and were treated with Levothyroxine. Six-week follow-up with TSH, pregnancy complications were observed.Results: 932 pregnant mothers were followed up. Prevalence of hypothyroidism was 10.5% (n = 98). Among the hypothyroid 62.24% (n = 61) had subclinical and 37.76% (n = 37) had overt hypothyroidism. The prevalence of anaemia was 35% in overt and 15% in subclinical hypothyroid group (p = 0.019). Preeclampsia is reported in 49% of overt and 16% of subclinical hypothyroid group (p = <0.001), statistically significant. Eclampsia was noted in 1 (1.64%) overt hypothyroid patient. Abruptio placenta was observed in 1 subclinical and 4 overt hypothyroid patients (5.1%). The incidence of preterm labour in this study subjects was 38% in overt and 20% in subclinical hypothyroid group (p = 0.048). The incidence of LBW fetus was 41% in overt hypothyroid and 21% in subclinical hypothyroid group (p = 0.041). The incidence of complication in this study was 41% in subclinical and 78% in overt hypothyroid group (p = <0.001).Conclusions: Early screening, adequate treatment and follow up will bring down maternal and fetal complications in hypothyroidism.
Background: The indications of primary ceasearean sections have been undergoing a gradual change over the last few decades. Besides the obstetric causes, several other medical, social, ethical, economic and medicolegal factors play an important role in the rising trend of ceasearean section. This study was conducted how to safely reduce the rate of primary caesearean section in both primiparous and multiparous women by analysis of its indications and to improve maternal and perinatal outcome. Objectives 1. To study the indications for the primary cesarean section in (Emergency &Elective/obstetrical and non-obstetrical indications) in both primiparous & multiparous women. 2. To study the maternal and fetal outcome after primary cesarean section. 3. To curtail primary cesaerean section in future by proper analysis of its Indications by conducting LSCS audit. Material and Methods: This prospective Cross sectional study was carried out in a tertiary care hospital, Chennai between March 1, 2018 to February 28, 2019. This study includes both nulliparous and multiparous women who are undergoing caesaerean section for the first time. Results: Total number of deliveries during one year period was 6718. Total no of caesearan sections during that period was 3229. Total number of primary caesearean sections was 1970. During my study period Cesaerean section rate was 48.06%. Primary ceasearean section rate was 36%. There was no maternal mortality in our study. Most common maternal morbidities are Paralytic ileus and puerperal fever seen in 18 cases each. 252 (42%) babies were admitted in NICU. Most common indications for NICU admissions were meconium aspiration syndrome and low birth weight. Perinatal mortality in the study was 7.9%. Perinatal mortality was high in patients with antepartum hemorrhage. Conclusion: Incidence of primary lscs was 36% at the 1 st phase of study. By conducting LSCS AUDIT, pitfalls were identified during the 2 nd phase, pitfalls are overcome by various training programmes and strict induction protocols in 3 rd phase, at the end of the study during 4 th phase we reduced the primary LSCS rate to 22%. And LSCSAUDIT is now ongoing to maintain and further safe reduction of primary ceaserean section.
Objectives and Methods: A retrospective study was conducted to investigate the maternal and fetal outcomes in term PROM by analysing the medical records of 246 patients, from February 2020 to July 2020. Data was entered in excel and analysed by SPSS version 21.0. Descriptive statistics was used for categorical variables. Results: Incidence of term PROM was 14% and it is common in primi gravida (54.9%), age group of 22 -25 years (42%). 73.6% of cases had induction followed by acceleration and 26.4% went for spontaneous labour. The time of delivery from PROM was 10% in <12 hours, 59% in 12 -24 hours and 31% in >24 hours. Vaginal delivery in 50.81% of cases and 49.19% by LSCS. Among the maternal co-morbidities, Pregnancy Induced Hypertension 6.1%, anemia 2.8% and Rhesus Negative 2.4%. 18.7% of neonates needed NICU care. Conclusion: PROM is associated with higher rate of induction and LSCS. Timely intervention will reduce the maternal and fetal morbidity and mortality.
To describe oligohydramnios in terms of age, parity, gestational age wise distribution, maternal morbidity and perinatal morbidity. Methods: A prospective study was carried out in Department of OBG, Govt Kilpauk Medical College Hospital, and Chennai. History, clinical examination and Ultrasound carried out to determine Amniotic fluid index for 12000 third trimester antenatal mothers in the study period. 150 patients detected with oligoamnios were followed up and analysis of outcome carried out. Results: The mean gestational age was 36.7+/-4.1 weeks. The mean amniotic fluid index was 3 +/-1.04cm. Gestational hypertension was present in 24% cases. 20% had postdated pregnancy. Incidence of intra uterine growth restriction was 14%. The rate of cesarean section was 63% and that of vaginal delivery was 35%. APGAR score of less than 7 at 1minute was noted in 16.66% and 5 minutes in 17.33% newborns. The gross perinatal mortality was 2.6%. Conclusion: All cases of oligohydramnios need careful antenatal evaluation, parental counseling, individualized decision regarding timing and mode of delivery. Continuous intrapartum fetal surveillance and good neonatal care are necessary for better perinatal outcome.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.